IMATINIB
imatinib 100 mg tablet, 60
IMATINIB (9123E)
9123E
Manner of administration:Oral
Restriction
Indication: Acute lymphoblastic leukaemia
Treatment phase: Induction and Consolidation therapy
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 1 | Max qty units: 60 | # of repeats: 2 | DPMQ: $99.84 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
|
|
|||||
|
|
|||||
|
|
|||||
|
|
|||||
|
|
|||||
|
|
|||||